PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1605761
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1605761
Artificial intelligence in diabetes management market size was valued at USD 21,234 Million in 2023, expanding at a CAGR of 38.5% from 2024 to 2032.
Artificial intelligence (AI) in diabetes management uses advanced algorithms and data-driven insights to monitor, predict, and optimize patient care. By analyzing blood glucose patterns, diet, exercise, and lifestyle data, AI systems offer personalized recommendations for medication dosing, dietary adjustments, and activity levels. This technology improves real-time decision-making, enhances glycemic control, and helps healthcare providers deliver proactive, efficient, and patient-specific diabetes management, ultimately reducing complications and promoting healthier outcomes.
Artificial Intelligence in Diabetes Management Market- Market Dynamics
Increasing prevalence of diabetes and technological advancements in AI to propel market demand
The global increase in diabetes cases fuels demand for AI-driven solutions in disease management. In 2021, the International Diabetes Federation reported 537 million adults with diabetes, a figure expected to reach 783 million by 2045. This surge amplifies the need for advanced, AI-enabled diabetes management tools. Besides, improved AI and machine learning capabilities drive the growth of AI in diabetes management market. However, the significant costs of deploying AI systems in healthcare act as a barrier. On the contrary, the global healthcare reforms and government initiatives are supporting AI-driven diabetes care, thereby boosting opportunities for the market.
Artificial Intelligence in Diabetes Management Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 38.5% over the forecast period (2024-2032)
Based on type segmentation, diagnostics was predicted to show maximum market share in the year 2023
Based on application segmentation, type 2 diabetes was the leading type in 2023
Based on deployment segmentation, cloud-based was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Artificial Intelligence in Diabetes Management Market is segmented on the basis of Type, Application, Deployment, End User, and Region.
The market is divided into four categories based on type: treatment planning, diagnostics, patient self-management, and diagnostics. The diagnostics sector dominates the market. This growth can be attributed to the the rising prevalence of diabetes and the growing emphasis on early detection.
The market is divided into three categories based on application: gestational diabetes, type 1 diabetes, and type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing prevalence of type 2 diabetes compared to type 1 diabetes.
Artificial Intelligence in Diabetes Management Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
The global market is expanding due to increased adoption of AI-driven tools for precise, data-oriented diabetes care. Companies in this market are focusing on partnerships with healthcare providers to integrate AI into existing diabetes monitoring systems, enabling real-time blood glucose analysis and personalized recommendations. Additionally, firms are investing in advanced AI algorithms to enhance predictive capabilities, facilitating early intervention and optimized treatment regimens to improve patient outcomes.
In March 2024, Roche introduced the AI-powered diabetes tracker, Accu-Chek SmartGuide, which uses real-time continuous glucose monitoring to predict blood sugar fluctuations up to two hours ahead.